Clene Inc. Warrant
CLNNW
About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Employees: 76
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
353.85% more ownership
Funds ownership: 13.03% [Q1] → 366.87% (+353.85%) [Q2]
0% more funds holding
Funds holding: 4 [Q1] → 4 (+0) [Q2]
29% less capital invested
Capital invested by funds: $28.2K [Q1] → $20.1K (-$8.1K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Financial journalist opinion
We haven’t received any recent news articles for CLNNW